Patient Characteristics In addition to age and gender, data on relevant comorbidities, laboratory results and GLP-1 RA prescribed dosing frequencies (weekly, daily) were extracted
And they will often present maybe with weight loss
Obesity Reviews , 23(5), e13456
Experts recommend 0.71.0 grams of protein per pound of target body weight during GLP-1 therapy to minimize muscle catabolism
Purpose-built for physicians Semaglutide could be practice changing for adults with diabetes, CKD The GLP-1 receptor agonist semaglutide may not only add another therapeutic option for chronic kidney disease, but it could also lead to changes in the way clinicians treat the condition
Certain conditions and medications require modified formulations or may contraindicate IV therapy entirely